Xtant Medical Holdings, Inc.: LYTTON LAURENCE W amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Laurence W. Lytton amended his Schedule 13G filing on Xtant Medical Holdings, Inc., updating his beneficial ownership stake in the medical device company, according to SEC accession 0000935836-26-000624. The filing reflects a change to a previously reported position, though the amended document did not immediately disclose the revised share count or percentage. Schedule 13G amendments are typically triggered when a passive investor's ownership crosses the 5% threshold or moves by more than 5% of the class. The update matters because it clarifies whether Lytton remains a significant holder in the small-cap orthobiologics firm. Investors will watch for the next 13F or 13G/A disclosure to confirm his current position size and any further accumulation or reduction.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
LYTTON LAURENCE W, Xtant Medical Holdings, Inc.